Reinhold Kerb
- Oncology top 0.5%
- Pediatrics, Perinatology and Child Health top 0.5%
- Molecular Biology top 5%
- Pharmacology top 0.1%
- Surgery top 2%
- Co-authors
- Ivar RootsUlrich BrinkmannJürgen BrockmöllerMatthias SchwabThomas LangElke SchaeffelerIngolf CascorbiMichel Eichelbaum
- Topics
- Drug Transport and Resistance Mechanisms (29 papers)Pharmacogenetics and Drug Metabolism (17 papers)Pharmacological Effects and Toxicity Studies (17 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Reinhold Kerb
69 papers receiving 6.5k citations
Peers
Comparison fields: 5 of 124
- Oncology 3.3k
- Pediatrics, Perinatology and Child Health 1.8k
- Molecular Biology 1.8k
- Pharmacology 1.6k
- Surgery 1.2k
Countries citing papers authored by Reinhold Kerb
This map shows the geographic impact of Reinhold Kerb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reinhold Kerb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reinhold Kerb more than expected).
Fields of papers citing papers by Reinhold Kerb
This network shows the impact of papers produced by Reinhold Kerb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reinhold Kerb. The network helps show where Reinhold Kerb may publish in the future.
Co-authorship network of co-authors of Reinhold Kerb
This figure shows the co-authorship network connecting the top 25 collaborators of Reinhold Kerb. A scholar is included among the top collaborators of Reinhold Kerb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reinhold Kerb. Reinhold Kerb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 18 | |
| 3 | 97 | |
| 4 | 306 | |
| 5 | 229 | |
| 6 | 79 | |
| 7 | 171 | |
| 8 | 58 | |
| 9 | 95 | |
| 10 | 124 | |
| 11 | 84 | |
| 12 | 78 | |
| 13 | 20 | |
| 14 | 210 | |
| 15 | 310 | |
| 16 | 15 | |
| 17 | 140 | |
| 18 | 53 | |
| 19 | 64 | |
| 20 | 88 |
About Reinhold Kerb
Reinhold Kerb is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health, having authored 69 papers that have together received 6.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (29 papers), Pharmacogenetics and Drug Metabolism (17 papers) and Pharmacological Effects and Toxicity Studies (17 papers). The work is most often cited by research in Pharmacology (1.6k citations), Oncology (3.3k citations) and Pediatrics, Perinatology and Child Health (1.8k citations). Reinhold Kerb has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Ivar Roots, Ulrich Brinkmann, Jürgen Brockmöller, Matthias Schwab, Thomas Lang, Elke Schaeffeler, Ingolf Cascorbi, Michel Eichelbaum, Céline Verstuyft and Laurent Becquemont. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.